Upload
medicineandhealth
View
1.524
Download
0
Tags:
Embed Size (px)
Citation preview
Chronic Urticaria and Angioedema
by the
Urticaria and Angioedema Committee
© AAAAI 2006
Angioedema vs Urticaria• Urticaria – involving the superficial dermis
– Most often characterized by intense pruritis due to histamine effect
• Angioedema – involving deeper dermal and subcutaneous layers– May be pruritic but often characterized as a
deeper and dull discomfort – burning quality
• Level of involvement may dictate detection and subsequent perception by patient
Chronic Urticaria/Angioedema(Mast cell driven)
0
10
20
30
40
50
60
70
80
% of Patients withChronic Urticaria
Women
Men40%50% 10 %
Urticaria& Angioedema
Urticaria Angioedema
Drug Induced Urticaria / Angioedema
Bradykinin responsible for swelling in angioedema in patients with HAE Kaplan A et al J Allergy Clin Immunol 2002;109:195-209
Angiotensin converting enzyme (ACE) inhibitors interfere with metabolism of bradykinin via interference with kininase Ii Gavras I Kidney Int 1992; 42:1020-29
Patients on angiotensin converting enzyme blockers (ARBs) may not be at risk for angioedema Gavras I Arch Int Med 2003; 163: 240-1
Hereditary Angioedema• Autosomal dominant with incomplete penetrance.
–Spontaneous mutations in 50%–Diminished C4 between attacks–Very low C4 during attacks
• HAE I–Low levels of C1 esterase inhibitor
• HAE II–Dysfunctional C1 INH
• HAE III (estrogen-dependent angioedema)–Normal C1 INH amount and function–Normal complement levels
Acquired Angioedema (AAE)
• Rare; Onset > 50 yo; negative familial history• AAE, type I
–Lymphoproliferative disorder–Monoclonal gamopathy, lymphoma,
lymphocytic leukemia• AAE, type II
–Autoantibodies to CI-INH• Low C1q levels in addition to depletion of C4
and C2.
Aspects cliniques
•Age de début•Localisation •Cinétique•Fréquence des crises•Facteurs déclenchants•Facteurs aggravants ( Inhibiteurs ACE, hormones)
• Inhibits C1r and C1s of the complement
system
• Inhibits activated factor XIIa and kallikrein
• An inhibitor of factor XIa and plasmin
• Inhibits activation of C1
C1 Inhibitor Functions
(Ecalantide)
Laboratory Tests for C1 Inhibitor Deficiency
• C4 low; C4d/C4 ratio always elevated
• C1 inhibitor protein low in about 85% of cases
• C1 inhibitor only functionally deficient in about
15%
• C1q antigen low in acquired deficiency
• Abnormal C1 inhibitor mobility (lower
molecular weight) on SDS gel electrophoresis
Treatment of Hereditary Angioedema• Patient education very important; test family• No regular medication needed in many cases• Prophylactic stanozolol or danozol• Epsilon aminocaproic acid (EACA) an option• Fresh frozen plasma before emergency
surgery• C1 inhibitor available in Europe but not in
the USA• Symptomatic treatment during attacks
Presentation of Urticaria• Patients typically present with pruritic and elevated papular
to plaque-like (plateau) elevations of skin• The duration of each lesion should help in defining the
type of urticaria and therapy– Less than 24 hours (each) suggestive of an IgE
mediated process and usually respond better with antihistamines
– Longer than 24 hours (each) implies cell mediated process (contact dermatitis, eczema), IgG/IgM antibody associated (i.e., serum sickness), or vasculitis that usually require steroids or other immuno-suppressants
Acute vs Chronic Urticaria• Acute Urticaria – lasts 6-8 weeks or less
– Viral syndromes (especially in young children)– Insect bites or stings (fire ants, scabies)– Food induced reactions (eat this- get that)– Medication related (antibiotics, NSAIDs, narcotics,
angioedema due to ACE inhibitors)• Chronic Urticaria – lasting longer than 8
weeks– Physical urticarias (dermographism, cholinergic,
cold)– Urticarial vasculitis – Urticaria/angioedema associated with
autoimmunity– Autoimmune urticaria– Idiopathic urticaria
Physical Urticarias• May occur so intermittently as to appear acute
but typically are chronic entities – most idiopathic
• Physical Urticarias– Symptomatic Dermatographism– Cholinergic– Cold Induced (Familial or Acquired)– Vibratory (angioedema)– Pressure – induced, Solar, Aquagenic
Physical urticaria
Symptomatic Dermatographism
• Simply scratching the skin promotes linear hives within minutes
• Delayed form described• Typically is short-lived in
duration (1/2 to 3 hours) and responds readily to antihistamines
Symptomatic Dermatographism
Cholinergic Urticaria
Cholinergic Urticaria
• Goal of raising body temperature (oral) by 0.7oC• Hot bath to 420C or having patient exercise
• Small pruritic papules result surrounded by erythema (but without hypotension) result
• Passive heat challenge may separate exercise-induced anaphylaxis from cholinergic urticariaCasale T et al. JAMA 1986; 255: 2049-2053
• Methacholine skin test insensitive (positive result in only 33% of patients with cholinergic urticaria)
Burrall B et al Western J Med 1990; 152: 268-76
Cholinergic urticaria
Cold-Induced Urticaria
• Familial (autosomal dominant) vs acquired (usually infection associated)
• Acquired form -positive ice-cube challenge
• Usually responds to cyproheptadine
Cold-induced urticaria
• Cold Stimulation Time Test (CSTT)– Positive in acquired cold-induced urticaria– Ice cubes and water in a plastic bag applied
to patient’s forearm up to 10 minutes– Urticaria results after warming of area– Timing of cold stimulus indirectly
proportional to severity (less time needed, worse symptoms upon exposure to cold)
• Many patients with good history for cold-induced urticaria may have negative CSTT
Diagnosis of cold-induced urticaria
Delayed Pressure Urticaria
Delayed Pressure Angioedema
• ~ 37% incidence of delayed pressure urticaria in chronic urticaria Barlow R et al. J Am Acad Dermatol 1993; 29: 954-8
• 15 pound weight suspended by thick strap over the shoulder and worn for 15 minutes– Typically, erythema with induration and
tenderness occurs at least 2 hours after the testSussman G et al J Allergy Clin Immunol
1982; 70: 337-42
Lawlor F et al Br J Dermatol 1989; 120: 93-99
Vibratory angioedema
Vortex to induce angioedema in a patient with swelling of hands while driving car
Solar Urticaria
• Phototesting performed with various light sources – sunlamp, blacklight, slide projector lamp
Horio T, Fukigaki K. J Am Acad Dermatol 1988; 18:
1189-93
• Differentiation from erythropoietic protoporphyria – lesions leave scarring– Analysis of red blood cells for
protoporphyrins– Stool for coproporphyrins
B Cell Lymphoma Associated with Symptomatic Dermatographism
Patient’s dermatographism resistant to fexofenadine and cetirizine sent a clue that something else may be causing her itching and hives.
Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS)
Hypocomplementemic urticarial vasculitis syndrome
•Urticaria/angioedema depressed C4
•Depresseed C1q
•Various etiologies, autoimmune diseasses
•Medicine 1995 74 24-41
Antibodies associated with urticaria
IgG auto ab to IgE receptor 35-40%
Antithyroglobulin Ab 8%
Antimicrosomal Ab 5%
Autologous Serum Skin Test• Serum obtained from patient
– 0.05 ml injected intradermally– Examination of wheal response at 30 minutes– Positive test is extension of wheal response by at
least 1.5 mm greater than original
• Patients with positive skin test associated with histamine-releasing FceRI autoantibodies– Patients with sera with histamine releasing activity
had more severe urticaria compared to those without
Sabroe RA et al. J Allergy Clin Immunol 2002; 110:
494-9
Autologous serum skin test
• Therapy with antihistamines work best for most patients with acute-types of short-lasting urticaria
• Combination therapy should be attempted if H1 antagonists do not suffice (30% of cases)
• Steroids and other immunosuppressants should be reserved for severe urticaria associated with angioedema of oropharnyx or other systemic signs, moderate to severe drug reactions, urticarial vasculitis, and refractory cases of CIU
Therapeutic options